Forma Therapeutics (Now Novo Nordisk)
Biotechnology ResearchMassachusetts, United States201-500 Employees
As of October, 2022, Forma Therapeutics has been acquired by Novo Nordisk.
Forma Therapeutics (Now Novo Nordisk) uses 8 technology products and services including AppNexus, SiteCatalyst, Cart Functionality, and more. Explore Forma Therapeutics (Now Novo Nordisk)'s tech stack below.
| Forma Therapeutics (Now Novo Nordisk) Email Formats | Percentage |
| FLast@formatherapeutics.com | 89% |
| FirstLast@formatherapeutics.com | 8% |
| Last@formatherapeutics.com | 2% |
| First@formatherapeutics.com | 1% |
| FLast@novonordisk.com | 80% |
| First.Last@novonordisk.com | 11% |
| FirstL@novonordisk.com | 7% |
| LastF@novonordisk.com | 2% |
Biotechnology ResearchMassachusetts, United States201-500 Employees
As of October, 2022, Forma Therapeutics has been acquired by Novo Nordisk.
Forma Therapeutics (Now Novo Nordisk) has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Dec 19, 2019 in the amount of $100M.
Forma Therapeutics (Now Novo Nordisk)'s revenue is estimated to be in the range of $25M$50M
Forma Therapeutics (Now Novo Nordisk) has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Dec 19, 2019 in the amount of $100M.
Forma Therapeutics (Now Novo Nordisk)'s revenue is estimated to be in the range of $25M$50M